NuVasive Inc. (NUVA) CFO and Executive VP Kevin C Oboyle sells 42,977 Shares

CFO and Executive VP of NuVasive Inc. (NUVA, Financial) Kevin C Oboyle sells 42,977 shares of NUVA on 12/15/2009 at an average price of $30 a share.

NUVASIVE is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products. Nuvasive Inc. has a market cap of $1.11 billion; its shares were traded at around $29.14 with a P/E ratio of 80.9 and P/S ratio of 4.5.

CEO Recent Trades:

  • Sell:: CEO and Chairman Alexis V Lukianov sold 20,000 shares of NUVA stock on 10/07/2009 at the average price of 41.66, the price of the stock has decreased by 30.05% since

  • Sell:: CEO and Chairman Alexis V Lukianov sold 20,000 shares of NUVA stock on 09/09/2009 at the average price of 39.11, the price of the stock has decreased by 25.49% since

  • Sell:: CEO and Chairman Alexis V Lukianov sold 20,000 shares of NUVA stock on 08/07/2009 at the average price of 42.43, the price of the stock has decreased by 31.32% since

  • Sell:: CEO and Chairman Alexis V Lukianov sold 20,000 shares of NUVA stock on 07/08/2009 at the average price of 39.88, the price of the stock has decreased by 26.93% since

  • Sell:: CEO and Chairman Alexis V Lukianov sold 20,000 shares of NUVA stock on 07/08/2009 at the average price of 39.88, the price of the stock has decreased by 26.93% since



CFO Recent Trades:

  • Sell:: CFO and Executive VP Kevin C Oboyle sold 2,968 shares of NUVA stock on 11/13/2009 at the average price of 39.72, the price of the stock has decreased by 26.64% since

  • Sell:: CFO and Executive VP Kevin C Oboyle sold 3,316 shares of NUVA stock on 10/14/2009 at the average price of 41.81, the price of the stock has decreased by 30.3% since

  • Sell:: CFO and Executive VP Kevin C Oboyle sold 2,185 shares of NUVA stock on 09/15/2009 at the average price of 42.25, the price of the stock has decreased by 31.03% since

  • Sell:: CFO and Executive VP Kevin C Oboyle sold 3,402 shares of NUVA stock on 09/15/2009 at the average price of 42.25, the price of the stock has decreased by 31.03% since

  • Sell:: CFO and Executive VP Kevin C Oboyle sold 8,152 shares of NUVA stock on 09/14/2009 at the average price of 41.99, the price of the stock has decreased by 30.6% since



Directors and Officers Recent Trades:

  • Buy:: Director Eileen M More bought 3,000 shares of NUVA stock on 12/01/2009 at the average price of 32.74, the price of the stock has decreased by 11% since

  • Sell:: Senior V.P., U.S. Sales Jeffrey P Rydin sold 900 shares of NUVA stock on 11/25/2009 at the average price of 34.49, the price of the stock has decreased by 15.51% since

  • Sell:: President and COO Keith Valentine sold 3,807 shares of NUVA stock on 11/19/2009 at the average price of 37.83, the price of the stock has decreased by 22.97% since

  • Sell:: SVP and General Counsel Jason Hannon sold 1,036 shares of NUVA stock on 11/10/2009 at the average price of 37.28, the price of the stock has decreased by 21.83% since

  • Sell:: Senior V.P., U.S. Sales Jeffrey P Rydin sold 1,238 shares of NUVA stock on 10/26/2009 at the average price of 39.6, the price of the stock has decreased by 26.41% since